# EVINA BIOSCIENCES, INC.: Development of First-in-Class, Non-Hormonal TDO2 Inhibitors for the Treatment of Uterine Fibroids

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | EVINA BIOSCIENCES, INC. |
| Location | EVANSTON, IL |
| Project | Development of First-in-Class, Non-Hormonal TDO2 Inhibitors for the Treatment of Uterine Fibroids |
| Project number | 1R43HD122564-01 |
| Mechanism | R43 |
| Institute | Eunice Kennedy Shriver National Institute of Child Health and Human Development |
| Award | $400,359 |
| Awarded | 2026-09-17 |
| Project period | 2026-09-20 to 2027-09-19 |
| UEI | QJ4GXZ5PDUD3 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11406015). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.
